MediFind found 375 doctor with experience in Non-Small Cell Lung Cancer (NSCLC) near Osaka, JP. Of these, 269 are Experienced, 74 are Advanced, 18 are Distinguished and 14 are Elite.
Hidetoshi Hayashi practices in Sayama, Japan. Hayashi is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Pancreaticoduodenectomy, and Tissue Biopsy.
Tomoya Kawaguchi practices in Osaka, Japan. Mr. Kawaguchi is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Endoscopy, and Tissue Biopsy.
Kazuhiko Nakagawa practices in Sayama, Japan. Nakagawa is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, Endoscopy, and Pancreatectomy.
Are you looking for a specific type of Non-Small Cell Lung Cancer (NSCLC)?
Common conditions include: EGFR Positive Lung Cancer, Large-Cell Lung Carcinoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
Hiroshige Yoshioka practices in Osaka, Japan. Yoshioka is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Mastectomy.
Tetsuya Mitsudomi practices in Sayama, Japan. Mr. Mitsudomi is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lymphadenectomy, and Tissue Biopsy.
Motohiro Tamiya practices in Osaka, Japan. Tamiya is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleural Effusion, EGFR Positive Lung Cancer, and Endoscopy.
Akihiro Tamiya practices in Chuo, Japan. Mr. Tamiya is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Pleural Effusion, and EGFR Positive Lung Cancer.
Tomonori Hirashima practices in Higashi-osaka, Japan. Hirashima is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Pleural Effusion, and Endoscopy.
Kazuto Nishio practices in Osaka, Japan. Mr. Nishio is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer, and Tissue Biopsy.
Kazumi Nishino practices in Chuo, Japan. Mr. Nishino is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Yasuhiro Tsutani practices in Sayama, Japan. Mr. Tsutani is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mastectomy, and Lymphadenectomy.
Hidekazu Suzuki practices in Osaka, Japan. Suzuki is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Indigestion, Helicobacter Pylori Infection, Lung Cancer, Endoscopy, and Colonoscopy.
Junichi Soh practices in Osaka, Japan. Mr. Soh is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Osteotomy, and Endoscopy.
Takayasu Kurata practices in Hirakata, Japan. Kurata is rated as an Elite expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Colonoscopy.
Haruko Daga practices in Osaka, Japan. Ms. Daga is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Kazuko Sakai practices in Sayama, Japan. Ms. Sakai is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer, and Tissue Biopsy.
Fumio Imamura practices in Osaka, Japan. Mr. Imamura is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.
Takayuki Shiroyama practices in Osaka, Japan. Mr. Shiroyama is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Pleural Effusion, and Endoscopy.
Kyoichi Okishio practices in Chuo, Japan. Okishio is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Pleural Effusion.
Hiroyasu Kaneda practices in Osaka, Japan. Kaneda is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Squamous Cell Lung Carcinoma.
Last Updated: 01/09/2026

